KAT7, for example, inhibits tumor cell proliferation and invasion by acetylating H4K5 at promoters of FOXO1 and FOXO3a genes [40], and HDAC5 loss increased H3K27-ac acetylation and circumvented oncogene-related cell cycle repression [41]. The gene discussed is FOXO3; the disease is neoplasm.